NCT01709253
Completed
Not Applicable
Phase 2 Hypofractionation Study Using Proton Beam Therapy for Prostate Adenocarcinoma
ConditionsProstate Adenocarcinoma
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Prostate Adenocarcinoma
- Sponsor
- National Cancer Center, Korea
- Enrollment
- 117
- Locations
- 1
- Primary Endpoint
- clinical outcomes
- Status
- Completed
- Last Updated
- 9 years ago
Overview
Brief Summary
Phase 2 hypofractionation study usion proton beam therapy for prostate adenocarcinoma
Investigators
Kwan Ho Cho
M.D.
National Cancer Center, Korea
Eligibility Criteria
Inclusion Criteria
- •Biopsy proven prostate adenocarcinoma Stage: T1-T2cN0M0 ECOG performance status: 0-2 Signed study specific informed consent prior to study entry
Exclusion Criteria
- •Postoperative residual or recurrent tumor Evidence of distant metastases Previous irradiation for the tumor in the same location Adjuvant anti-androgenic hormonal therapy High risk group (NCCN guide line)
Outcomes
Primary Outcomes
clinical outcomes
Time Frame: up to 5years from a initial follow-up
To evaluate biochemical failure-free survival (BCFFS)
Secondary Outcomes
- acute toxicity(up to 5years from a initial follow-up)
- late toxicity(up to 5years from a initial follow-up)
- overall survival(up to 5years from a initial follow-up)
Study Sites (1)
Loading locations...
Similar Trials
Completed
Not Applicable
Hypofractionated Proton Beam Radiotherapy for Inoperable Hepatocellular CarcinomaHepatocellular CarcinomaNCT02395523National Cancer Center, Korea45
Completed
Not Applicable
Hypofractionated Proton Beam Radiotherapy for Hepatocellular CarcinomaHepatocellular CarcinomaNCT01643824National Cancer Center, Korea112
Active, not recruiting
Phase 1
Hypofractionated Proton Beam Therapy for Localized Prostate CancerStage I Prostate Adenocarcinoma AJCC v7Stage II Prostate Adenocarcinoma AJCC v7NCT01950351M.D. Anderson Cancer Center241
Recruiting
Not Applicable
Prostate Cancer - Localized Adenocarcinoma Proton TherapyProstate AdenocarcinomaNCT03285815National Cancer Center, Korea156
Completed
Not Applicable
Short Course Radiotherapy for Localized Prostate CancerAdenocarcinoma of ProstateNCT03518853Tata Medical Center30